Dishman Pharma is currently trading at Rs. 59.70, up by 0.60 points or 2.50% from its previous closing of Rs. 57.20 on the BSE.

The scrip opened at Rs. 57.25 and has touched a high and low of Rs. 60.40 and Rs. 56.80 respectively. So far 6190 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 193.90 on 01-Oct-2010 and a 52 week low of Rs. 56.80 on 3-Oct-2011.

Last one week high and low of the scrip stood at Rs. 64.40 and Rs. 56.80 respectively. The current market cap of the company is Rs. 461.59 crore.

The promoters holding in the company stood at 61.20% while Institutions and Non-Institutions held 15.61% and 23.18% respectively.

Dishman Pharmaceuticals and Chemicals’ Switzerland based wholly owned subsidiary -- Carbogen Amcis AG -- has successfully completed US Food and Drug Administration (US FDA)  Pre Approval Inspection (PAI) for a new hi potency drug for a US multinational.

Carbogen Amcis is a leading service provider, offering a portfolio of drug development and commercialization services to the pharmaceutical and biopharmaceutical industry, at all stages of drug development.

Dishman Pharmaceuticals and Chemicals (DPCL) is engaged in manufacturing of Bulk API, Intermediates, Specialties and Quats. The company has started production of a range of phase transfer catalysts and quaternary ammonium and phosphonium compounds in 1989.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×